The following represents disclosure information provided by authors of this abstract. The Breast Cancer Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The INFORM HER2 Dual ISH assay compared with FISH to determine HER2 gene status in invasive breast carcinoma.
I. R. Loftin
Employment or Leadership Position - Ventana Medical Systems
A. McElhinny
Employment or Leadership Position - Ventana Medical Systems
R. Miller
Employment or Leadership Position - Ventana Medical Systems
C. Garcia
Employment or Leadership Position - Ventana Medical Systems
I. Bai
Employment or Leadership Position - Ventana Medical Systems
J. Ranger-Moore
Employment or Leadership Position - Ventana Medical Systems
J. Ostrem
Employment or Leadership Position - Ventana Medical Systems
M. Padilla
Employment or Leadership Position - Ventana Medical Systems
T. M. Grogan
Employment or Leadership Position - Ventana Medical Systems